PDCD1 and melanoma: In a recent study involving fecal transplantation from melanoma patients who were responders and nonresponders to anti-PD-1 therapy into melanoma-bearing germ-free mice, anti-PD-L1 therapy was effective in mice colonized with responder microbiota and ineffective in mice colonized with nonresponder microbiota [21].